
Nathaniel Herzfeld
Examiner (ID: 2727, Phone: (571)272-5899 , Office: P/3749 )
| Most Active Art Unit | 3762 |
| Art Unit(s) | 3743, 3749, 3762 |
| Total Applications | 626 |
| Issued Applications | 427 |
| Pending Applications | 1 |
| Abandoned Applications | 203 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9245330
[patent_doc_number] => 08609610
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-12-17
[patent_title] => 'Inhibitors of the trypsin-like site of the proteasome and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 13/723979
[patent_app_country] => US
[patent_app_date] => 2012-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 11
[patent_no_of_words] => 36505
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13723979
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/723979 | Inhibitors of the trypsin-like site of the proteasome and methods of use thereof | Dec 20, 2012 | Issued |
Array
(
[id] => 9676387
[patent_doc_number] => 08815295
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2014-08-26
[patent_title] => 'Anti respiratory syncytial virus peptide functionalized gold nanoparticles'
[patent_app_type] => utility
[patent_app_number] => 13/722517
[patent_app_country] => US
[patent_app_date] => 2012-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 15
[patent_no_of_words] => 5367
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13722517
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/722517 | Anti respiratory syncytial virus peptide functionalized gold nanoparticles | Dec 19, 2012 | Issued |
Array
(
[id] => 8904738
[patent_doc_number] => 20130172240
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-04
[patent_title] => 'METHODS FOR TREATING HCV'
[patent_app_type] => utility
[patent_app_number] => 13/718167
[patent_app_country] => US
[patent_app_date] => 2012-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3900
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13718167
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/718167 | METHODS FOR TREATING HCV | Dec 17, 2012 | Abandoned |
Array
(
[id] => 9812044
[patent_doc_number] => 20150023989
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-22
[patent_title] => 'NEW ANTIBODY DRUG CONJUGATES (ADCS) AND THE USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/364203
[patent_app_country] => US
[patent_app_date] => 2012-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 100637
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14364203
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/364203 | NEW ANTIBODY DRUG CONJUGATES (ADCS) AND THE USE THEREOF | Dec 11, 2012 | Abandoned |
Array
(
[id] => 8891133
[patent_doc_number] => 20130164317
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-27
[patent_title] => 'ANTIMICROBIAL AGENT, BACTERIAL STRAIN, BIOSYNTHESIS, AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 13/705936
[patent_app_country] => US
[patent_app_date] => 2012-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 24887
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13705936
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/705936 | Antimicrobial agent, bacterial strain, biosynthesis, and methods of use | Dec 4, 2012 | Issued |
Array
(
[id] => 8842222
[patent_doc_number] => 20130137850
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-30
[patent_title] => 'NOVEL POLYMER AND PROCESS FOR PRODUCING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 13/688988
[patent_app_country] => US
[patent_app_date] => 2012-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 8211
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13688988
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/688988 | NOVEL POLYMER AND PROCESS FOR PRODUCING THE SAME | Nov 28, 2012 | Abandoned |
Array
(
[id] => 10389778
[patent_doc_number] => 20150274785
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-01
[patent_title] => 'ANTI-INFLAMMATORY LIPOPEPTIDE AND PREPARING METHOD AND APPLICATION THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/440291
[patent_app_country] => US
[patent_app_date] => 2012-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 4550
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14440291
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/440291 | Anti-inflammatory lipopeptide and preparing method and application thereof | Nov 22, 2012 | Issued |
Array
(
[id] => 8733703
[patent_doc_number] => 20130079272
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-28
[patent_title] => 'METHODS OF PURIFYING POLYPEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 13/682620
[patent_app_country] => US
[patent_app_date] => 2012-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 33247
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13682620
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/682620 | METHODS OF PURIFYING POLYPEPTIDES | Nov 19, 2012 | Abandoned |
Array
(
[id] => 8822280
[patent_doc_number] => 20130123325
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-16
[patent_title] => 'USE OF BOCEPREVIR AND RELATED COMPOUNDS IN ATHEROSCLEROSIS, HEART FAILURE, RENAL DISEASES, LIVER DISEASES OR INFLAMMATORY DISEASES'
[patent_app_type] => utility
[patent_app_number] => 13/676741
[patent_app_country] => US
[patent_app_date] => 2012-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5259
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13676741
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/676741 | USE OF BOCEPREVIR AND RELATED COMPOUNDS IN ATHEROSCLEROSIS, HEART FAILURE, RENAL DISEASES, LIVER DISEASES OR INFLAMMATORY DISEASES | Nov 13, 2012 | Abandoned |
Array
(
[id] => 9034974
[patent_doc_number] => 20130237612
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-12
[patent_title] => 'LEUCINE BETA ROLL DOMAINS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/674283
[patent_app_country] => US
[patent_app_date] => 2012-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 14799
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13674283
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/674283 | Leucine beta roll domains and uses thereof | Nov 11, 2012 | Issued |
Array
(
[id] => 9676896
[patent_doc_number] => 08815805
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-08-26
[patent_title] => 'Formulations having an antagonist of α5β1 for anti-angiogenesis and cancer treatment'
[patent_app_type] => utility
[patent_app_number] => 13/671462
[patent_app_country] => US
[patent_app_date] => 2012-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 11524
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13671462
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/671462 | Formulations having an antagonist of α5β1 for anti-angiogenesis and cancer treatment | Nov 6, 2012 | Issued |
Array
(
[id] => 9589551
[patent_doc_number] => 08779091
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-07-15
[patent_title] => 'Methods for selective targeting'
[patent_app_type] => utility
[patent_app_number] => 13/658713
[patent_app_country] => US
[patent_app_date] => 2012-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 13
[patent_no_of_words] => 16904
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13658713
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/658713 | Methods for selective targeting | Oct 22, 2012 | Issued |
Array
(
[id] => 8767087
[patent_doc_number] => 20130095123
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-04-18
[patent_title] => 'New binder-drug conjugates (ADCs) and use thereof'
[patent_app_type] => utility
[patent_app_number] => 13/656681
[patent_app_country] => US
[patent_app_date] => 2012-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 122622
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13656681
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/656681 | Binder-drug conjugates (ADCs) and use thereof | Oct 19, 2012 | Issued |
Array
(
[id] => 8780551
[patent_doc_number] => 20130102526
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-04-25
[patent_title] => 'Methods for Treating HCV'
[patent_app_type] => utility
[patent_app_number] => 13/656012
[patent_app_country] => US
[patent_app_date] => 2012-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 60759
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13656012
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/656012 | Methods for treating HCV | Oct 18, 2012 | Issued |
Array
(
[id] => 8780551
[patent_doc_number] => 20130102526
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-04-25
[patent_title] => 'Methods for Treating HCV'
[patent_app_type] => utility
[patent_app_number] => 13/656012
[patent_app_country] => US
[patent_app_date] => 2012-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 60759
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13656012
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/656012 | Methods for treating HCV | Oct 18, 2012 | Issued |
Array
(
[id] => 8780551
[patent_doc_number] => 20130102526
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-04-25
[patent_title] => 'Methods for Treating HCV'
[patent_app_type] => utility
[patent_app_number] => 13/656012
[patent_app_country] => US
[patent_app_date] => 2012-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 60759
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13656012
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/656012 | Methods for treating HCV | Oct 18, 2012 | Issued |
Array
(
[id] => 8780551
[patent_doc_number] => 20130102526
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-04-25
[patent_title] => 'Methods for Treating HCV'
[patent_app_type] => utility
[patent_app_number] => 13/656012
[patent_app_country] => US
[patent_app_date] => 2012-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 60759
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13656012
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/656012 | Methods for treating HCV | Oct 18, 2012 | Issued |
Array
(
[id] => 9720925
[patent_doc_number] => 20140256626
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-11
[patent_title] => 'PEG CONJUGATES OF EXENATIDE'
[patent_app_type] => utility
[patent_app_number] => 14/352644
[patent_app_country] => US
[patent_app_date] => 2012-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7286
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14352644
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/352644 | PEG CONJUGATES OF EXENATIDE | Oct 16, 2012 | Abandoned |
Array
(
[id] => 9041105
[patent_doc_number] => 20130243743
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-19
[patent_title] => 'METHODS AND COMPOSITIONS FOR TREATING INEFFECTIVE ERYTHROPOIESIS'
[patent_app_type] => utility
[patent_app_number] => 13/654191
[patent_app_country] => US
[patent_app_date] => 2012-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 38
[patent_no_of_words] => 36952
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13654191
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/654191 | METHODS AND COMPOSITIONS FOR TREATING INEFFECTIVE ERYTHROPOIESIS | Oct 16, 2012 | Abandoned |
Array
(
[id] => 9772487
[patent_doc_number] => 20140296151
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-02
[patent_title] => 'PEPTIDES FROM FISH GELATINE'
[patent_app_type] => utility
[patent_app_number] => 14/350523
[patent_app_country] => US
[patent_app_date] => 2012-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3798
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14350523
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/350523 | PEPTIDES FROM FISH GELATINE | Oct 11, 2012 | Abandoned |